Skip to main content

13 July 2026

Last updated: Monday 13 July 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

The risks of therapeutic genome editing

Sunday 25 June 2017

Interviewee/Contributor

Houria Bachtarzi and Tim Farries

Organisation

ERA Consulting (UK) Ltd

Organisations

Kiadis Pharma BV
Autifony Therapeutics Ltd
SparingVision SAS
Transimmune AG
US Food and Drug Administration
European Forum for Good Clinical Practice
Omnix Medical
Kilburn & Strode LLP
Complix NV
Destiny Pharma Plc

Interviewees and Contributers

Matthias Heck
Désiré Collen
David Berman and Marcel Zwaal
Ceri Wiggins and Jon Moore
Mick Cooper
Richard C. Ascroft et al
David Mott
Klaus Breiner
Dolores Schendel
Moshik Cohen-Kutner and Niv Bachnoff

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Evotec names head of in silico and AI

Saturday 20 June 2026

Forbion promotes senior officers, appoints operating partner

Saturday 20 June 2026

Specialist CDMO Ardena appoints CSO

Saturday 20 June 2026

CellaVision names CEO

Saturday 20 June 2026

FundaMental Pharma names CMO to lead depression candidate

Saturday 20 June 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form